Exhibit 32.2

                            CERTIFICATION PURSUANT TO

                             18 U.S.C. SECTION 1350,

                             AS ADOPTED PURSUANT BY

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 Inconnection with the Quarterly
Report of Innovate Oncology, Inc., on Form 10-QSB for the period ending March
31, 2005 as filed with the Securities and Exchange Commission on the date hereof
(the "Report" ), the undersigned, Alan Bowen, Chief Financial Officer and
Principal Accounting Officer of the Company, certify, pursuant to 18 U.S.C.
1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of section 13 (a) or 15 (d)
of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material
respects, the financial condition and result of operations of the Company.



                             Date: August 22, 2005

                             By: /s/ Alan Bowen
                             ------------------------------------
                             Alan Bowen
                             CFO, Secretary, Treasurer & Director
                             (Principal Financial Officer)



A signed original of this written statement required by Section 906, or other
document authenticating, acknowledging, or otherwise adopting the signature that
appears in typed form within the electronic version of this written statement
has been provided to the Company and will be retained by the Company and
furnished to the Securities and Exchange Commission or its staff upon request.


                                       22

                                  End of Filing